TY  - GEN
AU  - Smyth,Mark J
AU  - Hayakawa,Yoshihiro
AU  - Cretney,Erika
AU  - Zerafa,Nadeen
AU  - Sivakumar,Pallavur
AU  - Yagita,Hideo
AU  - Takeda,Kazuyoshi
TI  - IL-21 enhances tumor-specific CTL induction by anti-DR5 antibody therapy
SN  - 0022-1767
PY  - 2006///0622
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cell Line, Tumor
KW  - Cytotoxicity, Immunologic
KW  - Interleukins
KW  - Lymphocyte Activation
KW  - immunology
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Mice, SCID
KW  - Receptors, TNF-Related Apoptosis-Inducing Ligand
KW  - Receptors, Tumor Necrosis Factor
KW  - T-Lymphocytes, Cytotoxic
KW  - Interleukin-21
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.4049/jimmunol.176.10.6347
ER  -